A Trial to Learn How BAY1834845 and BAY1830839 Affect Inflammation When Taken by Mouth Twice a Day for 7 Days in a Row in Healthy Male Participants

NCT05003089 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Immune Mediated Inflammatory Diseases

Interventions

DRUG: BAY1834845
DRUG: BAY1830839
DRUG: Prednisolone
DRUG: Placebo

Sponsor

Bayer